home

research and development

nanoflex technology

applications

breast implant
technology
     
  Nanoflex™ Technology Applications  
  Breast Implant pre-clinical development plan  
     
 
  • 28 Day Mouse Toxicology Study
    • Completed
  • 14 Day Rabbit Toxicology Studies
    • Completed
  • GLP Toxicology Studies
    • Completed for pHPMA and pHEMA
  • 180 Day Porcine Rupture Study
    • Commence 2nd Quarter 2007
 
     
  Viscous Gel 14 Day Toleration Study  
 
  • 50 g of rhodamine-labeled gel encased in a ruptured breast implant shell was surgically implanted in a rabbit.
  • After 14 days the implant was excised and the entire gel was found aggregated at the rupture site as an intact hydrogel mass.
  • Gross observation of draining lymph nodes, lungs, liver and spleen showed no migration of gel.
  
 
 Viscous Gel 14 Day Toleration Study
  
  Potential Product Advantages  
 
  • Aesthetics of silicone
  • Safety of saline
  • “Self Sealing”, non-migrating material
  • “Non-Bleed” material
  • Various Softness
  • Lighter material than silicone
 
     

Other applications Wound Care, Topical, Dermal and Ocular

 

 

© 2010 ULURU Inc.
Latest News
ULURU Inc. developed and commercializes Altrazeal™, a transforming powder dressing with proprietary Nanoflex™ technology, for the management of exuding wounds.
Visit www.altrazeal.com
for clinical case studies, patient testimonials, application guidelines, and much more…